Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins

PM Abuja, R Albertini - Clinica chimica acta, 2001 - Elsevier
After a brief discussion of lipid peroxidation mechanism and the action of antioxidants and
their potential to exhibit prooxidant effects, we give an overview on the clinical relevance of …

Biomarkers in toxicology and risk assessment: informing critical dose–response relationships

…, T Starr, VE Walker, RJ Albertini - Chemical research in …, 2008 - ACS Publications
Tremendous advances have been made in the study of biomarkers related to carcinogenesis
during the past 20 years. This perspective will briefly review improvements in methodology …

Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies

R Albertini, R Moratti, G Luca - Current molecular medicine, 2002 - ingentaconnect.com
Although it has been known for long time that atherosclerosis is associated with lipid
deposition, only recently it has been accepted that the plasmatic concentration of cholesterol, …

IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans

RJ Albertini, D Anderson, GR Douglas… - … Research/Reviews in …, 2000 - Elsevier
The purpose of these guidelines is to provide concise guidance on the planning, performing
and interpretation of studies to monitor groups or individuals exposed to genotoxic agents. …

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome

FH Bach, RJ Albertini, P Joo, JL Anderson, MM Bortin - The Lancet, 1968 - Elsevier
… who are only slightly incompatible at HL-A (Albertini and Bach 1968). Histocompatibility testing
will be … FHB is an established investigator of the American Heart Association, and R. J. A. …

T cells responsive to myelin basic protein in patients with multiple sclerosis

M Allegretta, JA Nicklas, S Sriram, RJ Albertini - Science, 1990 - science.org
… We thank the following for their generous gifts of reagents: WS Wold for E19-specific rabbit
antiserun, R. Ricciardi for the genomic AdS fragment containing the E19 gene, D. Margulies …

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

…, AD Ho, MV Rosin, R Albertini, R Moratti… - Blood, The Journal …, 2014 - ashpublications.org
The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis,
but little is known on progression or reversibility of renal involvement, and criteria for renal …

Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder

KA Phillips, J Grant, J Siniscalchi, RS Albertini - Psychosomatics, 2001 - Elsevier
It appears that many individuals with body dysmorphic disorder (BDD) receive nonpsychiatric
medical treatment and surgery; however, this topic has had little systematic investigation. …

Low-level laser therapy induces dose-dependent reduction of TNFα levels in acute inflammation

F Aimbire, R Albertini, MTT Pacheco… - … and laser surgery, 2006 - liebertpub.com
Objective: The aim of this study was to investigate if low-level laser therapy (LLLT) can
modulate acute inflammation and tumor necrosis factor (TNFα) levels. Background Data: Drug …

A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder

KA Phillips, RS Albertini… - Archives of general …, 2002 - jamanetwork.com
Background Research on the pharmacotherapy of body dysmorphic disorder (BDD), a
common and often disabling disorder, is limited. Available data suggest that this disorder may …